Incidence of new Primary Malignancies Among Patients With Bone Metastases From Breast, Prostate, or Lung Cancer Treated With XGEVA or Intravenous Zoledronic Acid: a Retrospective Cohort Study (20170728)First published 26/09/2018 Last updated 28/02/2020 EU PAS number: EUPAS25381StudyFinalised